For the Quarter Ending September 2025
North America
• In the United States, Sulfamethazine Price Index rose in Q3 2025, driven by costs.
• Sulfamethazine production costs increased in Q3 2025, as PPI rose 2.6% year-over-year in August.
• Demand for Sulfamethazine faced headwinds in Q3 2025, with the US cattle herd contracting in July.
• Overall chemical inventories shrank in Q3 2025 due to accelerated industry-wide destocking efforts.
• US natural gas prices experienced a year-over-year uptick in Q3 2025, influencing manufacturing expenses.
• Robust consumer spending, with retail sales up 5.42% in September 2025, supported animal product demand.
• Consumer confidence declined to 94.2 in September 2025, potentially dampening demand for animal products.
• Benzene feedstock costs strengthened in Q3 2025, contributing to higher overall chemical production expenses.
• Industrial production was nearly stagnant (0.1% year-over-year) in September 2025, reflecting economic sluggishness.
• The unemployment rate was 4.3% in September 2025, indicating a stable labor market supporting consumer purchasing.
Why did the price of Sulfamethazine change in September 2025 in North America?
• Rising operational costs, with CPI up 3.0% in September 2025, pressured Sulfamethazine prices upward.
• Strengthening benzene feedstock costs in Q3 2025 contributed to higher Sulfamethazine production expenses.
• Weak overall chemical demand in Q3 2025 created mixed price pressures despite robust retail.
Europe
• In Germany, the Sulfamethazine Price Index fell in Q3 2025, due to decreasing producer input costs and contracting industrial activity.
• Sulfamethazine production costs decreased as the PPI fell 1.7% year-on-year in September 2025.
• Aniline feedstock costs declined in Q3 2025, lowering Sulfamethazine manufacturing expenses.
• The Manufacturing Index was contracting in September 2025, signaling weakening industrial demand.
• Industrial production decreased 1.0% year-on-year in September 2025, impacting Sulfamethazine demand.
• Veterinary healthcare demand for Sulfamethazine grew steadily in 2025, supported by companion animal ownership.
• Consumer confidence remained significantly negative at -23.6 in September 2025, limiting overall market demand.
• Ample chemical industry inventories in Q3 2025, with elevated Aniline levels, indicated oversupply.
• German chemical sales outside Europe fell significantly in Q3 2025, affecting export demand.
• Sulfamethazine Price Forecast suggests continued pressure due to ample supply and subdued industrial demand.
Why did the price of Sulfamethazine change in September 2025 in Europe?
• Producer input costs for Sulfamethazine decreased; PPI fell 1.7% in September 2025.
• Industrial demand for Sulfamethazine contracted; Manufacturing Index showed contracting trend in September 2025.
• Ample chemical inventories in Q3 2025, with elevated Aniline levels, created oversupply.
APAC
• In China, the Sulfamethazine Price Index remained stable in Q3 2025, reflecting mixed macroeconomic signals.
• Sulfamethazine production costs faced upward pressure in Q3 2025, driven by marginal Aniline feedstock cost increases.
• Demand for Sulfamethazine was bolstered by expanded animal husbandry and aquaculture output during 2025.
• The Sulfamethazine Price Forecast indicated stability, despite a contracting Manufacturing Index in September 2025.
• Sulfuric acid inventories tightened by late Q3 2025, pressuring Sulfamethazine production expenses upward.
• China's industrial production rose 6.5% year-on-year in September 2025, supporting demand for animal products.
• Retail sales grew 3.0% year-on-year in September 2025, sustaining consumer demand for animal-derived products.
• Deflationary CPI, at -0.3% year-on-year in September 2025, signaled reduced consumer purchasing power.
• Producer Price Index declined 2.3% year-on-year in September 2025, indicating weak industrial demand affecting agriculture.
• A stable unemployment rate of 5.2% in September 2025 supported consumer purchasing power for food products.
Why did the price of Sulfamethazine change in September 2025 in APAC?
• Aniline feedstock costs marginally increased in Q3 2025, raising Sulfamethazine production expenses.
• Deflationary CPI of -0.3% in September 2025 indicated reduced consumer purchasing power.
• Robust industrial production, up 6.5% in September 2025, supported animal husbandry demand.
For the Quarter Ending December 2022
North America
The price of Sulfamethazine in the North American market fell in the fourth quarter of 2022, with CFR New York prices settling at USD 14920/MT in October Due to sluggish demand from the American downstream pharmaceutical sector.
The production rate was kept at its peak despite low domestic consumption rates. In the domestic US market, these prices did, however, decrease further in December to USD 14580/MT. The US supply chain progressively improved in H2 of 2022 as the US economy finally started to revive and the port on the east coast drastically reduced ship backlogs.
The US supply chains were adaptable, which led to a drop in product costs because of the decreased shipping demand brought on by slower consumer spending and a loss in industrial activity.
Asia- Pacific
Sulfamethazine prices in the Asia-Pacific area kept declining during the fourth quarter of 2022, dropping to USD 12650/MT in December after settling at USD 12900/MT in October due to sluggish demand from downstream pharmaceutical businesses. A modest pace of contraction in the manufacturing sector this month was caused by the Golden week shutdown of industrial facilities in China from October 1 to October 7. End-user run rate limits and logistical constraints brought on by the reappearance of Covid cases at the end of October generated a build-up of Sulfamethazine inventory and decreased offers. Additionally, prices dropped as shoppers kept buying what they needed despite the local market's dropping demand.
Europe
Not only in North America and the Asia-Pacific region but also in Europe, the Sulfamethazine market had somewhat similar market dynamics, with prices falling in the fourth quarter of 2022. Market sentiment for German Sulfamethazine declined, with CFR Hamburg prices assessed at USD 15980/MT in October and dropping even further to USD 15720/MT in December. Due to negative market sentiments, domestic demand was lower than anticipated, particularly from the key end-user pharmaceutical industry. Because import prices from Asian nations were low, market insiders had a gloomy outlook. Large stock levels additionally pushed merchants to cut their prices to clear off their immense stocks. Moreover, when worries about port congestion subsided, the price of transporting goods from Asia to Europe was reduced.
For the Quarter Ending September 2022
North America
With prices assembled at USD 15550/MT in July, the North American Sulfamethazine market started in Q3 of 2022 with stable sentiments. Entering July, buyers only made purchases for instant use caused of both the steady offtakes and the moderate end-user demand. However, Sulfamethazine prices slightly increased as August approached due to an improvement in orders but dropped again by the termination of Q3. The US mainly imported Sulfamethazine from China, whereas most factories in China were under maintenance, resulting in lower imports into the US. Therefore, towards the end of Q3, the CFR New York prices of Sulfamethazine were evaluated at USD 15160/MT.
Asia- Pacific
The Asia-Pacific Sulfamethazine market commenced the 3rd quarter of 2022 on a negative note, with a 4.1% decrement in prices. However, values started inclining from mid-H1 and declined again in the last weeks of the quarter. Therefore, continuous variation in price trends was due to several factors, such as the unstable supply of inventories in the domestic market and flickering demand from the end-user pharmaceutical sector. In addition, turbulences in factory production were seen due to lockdown restrictions, a turnaround of manufacturing facilities for maintenance, and a severe power crunch driven by extreme heat waves and drought. As a ripple effect, the FOB Shanghai prices of Sulfamethazine settled at USD 13950/MT in September 2022.
Europe
During the third quarter of 2022, Sulfamethazine's price on the European market fluctuated, mirroring the pricing pattern on the North American and Asian markets. In July, the lack of interest from the downstream pharmaceutical industry inquiring about Sulfamethazine in the German domestic market lowered market sentiments. Sulfamethazine prices increased in August; however, this was due to logistical problems and a lack of supplies. Additionally, China's import activities into Germany were unstable for several reasons, including frequent lockdowns, factory closures, and high-temperature maintenance. Therefore, when the threat of a recession loomed from late August to the last week of September, dealers were ready to negotiate over the purchases. As a result, towards the quarter's conclusion, Sulfamethazine pricing in Germany was fixed at USD 16160/MT.
For the Quarter Ending June 2022
North America
In the second quarter of 2022, the US Sulfamethazine API trend had a declining movement due to sufficient product availability and low purchasing appetite in the region. Sulfamethazine API's price decreased in the North American region as trade remained sluggish due to less expensive imports suppressing demand. Moreover, imports in the United States remained usual, with stockpiling products pressuring the end-user to clear their existing stocks, further resulting in lower prices in the North American regional market. From April, there was a noticeable decrement in the Sulfamethazine API market. This represented discouraging indicators of demand from downstream pharmaceutical sectors and was significantly lower than in previous months. The CFR prices for Sulfamethazine API were evaluated at USD 17900/MT in the United States at the end of the quarter.
Asia- Pacific
During the second quarter of 2022, the Sulfamethazine API market showcased mixed sentiments in the Asia-Pacific region. In the first half of the second quarter, the supply side continued to increase; there was negative pressure on the spot market. The utilization rate of domestic Sulfamethazine API enterprises continues to decline. Decreased prices of raw materials such as Pyridine and Acetylacetone also impacted the price trend of Sulfamethazine API. From May end, manufacturers started working towards uplifting the market with recovering behavior, but the overall market was still on the lower side; the overall demand entered the average level at the end of June. Thus, by the quarter ending June, the FOB prices of Sulfamethazine API settled at USD 14800/MT in China.
Europe
In European nations, Sulfamethazine prices witnessed a negative trend in the second quarter of 2022 compared to the first quarter. From April, Sulfamethazine prices plunged amidst sluggish buying and the availability of low imports. Sulfamethazine prices have fallen amid slow trading activity, import pressure, and inexpensive raw materials. Weak demand, customer destocking, and competitive import prices continued to drag down European Sulfamethazine. With a quarterly declination of 10.6%, prices of Sulfamethazine API in Germany settled at USD 16000/MT in June.
